SCHEMBL9059672

SCHEMBL9059672

NC(=Nc1ccccc1-c1ccccc1)N1CCCC(CO)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.46
RAB9A P51151 5/20 0.45
NPC1 O15118 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
ALDH1A1 P00352 1/20 0.45
GAA P10253 1/20 0.45
MAPT P10636 1/20 0.45
HTT P42858 2/20 0.42
EPHX2 P34913 2/20 0.41
SIGMAR1 Q99720 4/20 0.40
CHRNB2 P17787 3/20 0.40
CHRNA4 P43681 3/20 0.40
CHRNB4 P30926 2/20 0.40
CHRNA3 P32297 2/20 0.40
POLB P06746 2/20 0.40
KMT2A Q03164 1/20 0.40
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9060426 0.85 SIGMAR1 (0.42) SMN1; SMN2ALDH1A1HTTSIGMAR1CHRNB2
SCHEMBL9060099 0.85 SIGMAR1 (0.47) CYP2D6SIGMAR1CHRNB2CHRNA4CHRNB4
SCHEMBL9059479 0.81 CHRNB2 (0.40) RAB9ANPC1ALDH1A1SIGMAR1CHRNB2
SCHEMBL9061357 0.80 SIGMAR1 (0.60) CYP2D6RAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL9059245 0.80 SIGMAR1 (0.44) SMN1; SMN2SIGMAR1CD274
SCHEMBL9059900 0.77 SIGMAR1 (0.49) RAB9ANPC1SMN1; SMN2GAAMAPT
SCHEMBL9059944 0.76 SIGMAR1 (0.48) RAB9ASMN1; SMN2ALDH1A1GAASIGMAR1
SCHEMBL9059625 0.73 SIGMAR1 (0.39) SMN1; SMN2ALDH1A1HTTSIGMAR1POLB
SCHEMBL9059465 0.72 SIGMAR1 (0.45) EPHX2SIGMAR1CHRM3
SCHEMBL9059367 0.72 SIGMAR1 (0.46) RAB9ANPC1ALDH1A1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996017612-A1 USE OF SUBSTITUTED PHENYLAMIDINE AND PHENYLGUANIDINE COMPOUNDS FOR THE TREATMENT OF CEREBRAL AND CARDIAC ISCHAEMIA, CONVULSION AND SICKLE CELL ANAEMIA KNOLL AKTIENGESELLSCHAFT (DE) 1996-06-13 WO disclosed
EP-0536151-B1 ORTHOSUBSTITUTED BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM BOOTS CO PLC (GB) 1994-09-14 EP disclosed
US-5302720-A Biphenyl-substituted guanidine derivatives useful as hypoglycaemic agents THE BOOTS COMPANY (GB) 1994-04-12 US disclosed
EP-0536151-A1 ORTHOSUBSTITUTED BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM. BOOTS CO PLC (GB) 1993-04-14 EP disclosed
WO-1992000273-A1 ORTHOSUBSTITUTED BIPHENYL AMIDINE AND BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM THE BOOTS COMPANY PLC (GB) 1992-01-09 WO disclosed